Click on image to view larger version.
Fig 1. Reporter gene imaging. A, Schematic diagram of the principle of reporter gene imaging by using the enzyme firefly luciferase. Once the cell is transduced with a viral vector containing the imaging gene cassette, a promoter of choice drives the transcription of the imaging reporter gene (Fluc). If the promoter leads to transcription of Fluc, then translation of the imaging reporter gene mRNA leads to a protein product (the enzyme firefly luciferase) that can interact with the imaging reporter probe (D-Luciferin). This interaction is a chemiluminescent reaction that catalyzes the transformation of the substrate D-Luciferin into oxyluciferin in a process dependent on ATP, Mg++, and O2, leading to the emission of light, which can be detected by using low-light sensing instruments. Other gene/substrate combinations may be used as well (eg, hRluc and its substrate CL, see text). B, Bioluminescence neuroimaging in mice. Balb/c mice with 105 intracranially injected N2a cells transfected 24 hours previously with CMV-hRluc (right) and CMV-Fluc (left). Intracranial injections were performed immediately before substrate administration. The mice received intraperitoneal injections of the substrates D-Luciferin (1.5 mg) or CL (5µg) respectively. The charge-coupled device camera images were taken approximately 5–7 minutes post-substrate injections. Maximum signal intensity detected in photons per second per square centimeter per steradian is the following: Fluc, 2.1 x 106; hRluc, 9.2 x 104. CMV indicates cytomegalovirus; CMV-FL, adenoviral vector containing an imaging cassette with the CMV promoter driving the transcription of firefly luciferase gene.
